Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q79798337)
Watch
English
Multiple myeloma
scientific article published on 01 March 2004
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Multiple myeloma
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
author name string
Bhawna Sirohi
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
Ray Powles
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
language of work or name
English
0 references
publication date
1 March 2004
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
volume
363
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
issue
9412
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
page(s)
875-887
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
cites work
Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose intravenous melphalan for plasma-cell leukaemia and myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Single versus double autologous stem-cell transplantation for multiple myeloma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple myeloma: evolving genetic events and host interactions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Karyotyping human chromosomes by combinatorial multi-fluor FISH.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and biologic implications of recurrent genomic aberrations in myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hypodiploidy is a major prognostic factor in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel therapies for multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel therapies targeting the myeloma cell and its bone marrow microenvironment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: regulation during interleukin-6(IL-6)-induced growth and survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Insulinlike growth factor-I signaling in multiple myeloma: downstream elements, functional correlates, and pathway cross-talk
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Death receptors: signaling and modulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple Myeloma. Advances in disease biology: therapeutic implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytogenetic findings in 200 patients with multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A molecular compendium of genes expressed in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Changing clinical presentation of multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
"Benign" monoclonal gammopathy--after 20 to 35 years of follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective study of serum protein capillary zone electrophoresis and immunotyping of monoclonal proteins by immunosubtraction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple myeloma treated with high dose intravenous melphalan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results of autologous stem cell transplant in multiple myeloma patients with renal failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial experience of the Intergroupe Francophone du Myélome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Graft-versus-myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Allogeneic hematopoietic cell transplantation for multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of previous high-dose therapy on outcome after allografting for multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monoclonal Antibody-Purged Bone Marrow Transplantation Therapy for Multiple Myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon therapy in myelomatosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Should-alpha-interferon be included as standard treatment in multiple myeloma?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Myeloma bone disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bone marrow angiogenesis and progression in multiple myeloma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antitumor activity of thalidomide in refractory multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide in multiple myeloma: current status and future prospects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide alone or with dexamethasone for previously untreated multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How proteolysis drives the cell cycle
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase 2 study of bortezomib in relapsed, refractory myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Trials of Arsenic Trioxide in Multiple Myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RANK-Fc: a therapeutic antagonist for RANK-L in myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of farnesyl transferase inhibitor R115777 on the growth of fresh and cloned myeloma cells in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Some early phase II trials in previously untreated multiple myeloma: The Royal Marsden experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915736-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(04)15736-X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
PubMed publication ID
15031034
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15031034
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15031034%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
